Adenovirus-mediated FasL gene transfer into human gastric carcinoma

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 22

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Jun 14, 2005; 11(22): 3446-3450
Published online Jun 14, 2005. doi: 10.3748/wjg.v11.i22.3446

Table 2 Relative in vitro cytotoxicities of various treatments (mean±SD).

^aP<0.05 vs CH-11 or (compared with CH-11 or anti-Fas antibody+ActD),

^bP<0.01 vs ActD (compared with ActD).

Citation: Zheng SY, Li DC, Zhang ZD, Zhao J, Ge JF. Adenovirus-mediated FasL gene transfer into human gastric carcinoma. World J Gastroenterol 2005; 11(22): 3446-3450
URL: https://www.wjgnet.com/1007-9327/full/v11/i22/3446.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i22.3446

Zheng SY, Li DC, Zhang ZD, Zhao J, Ge JF. Adenovirus-mediated FasL gene transfer into human gastric carcinoma. World J Gastroenterol 2005; 11(22): 3446-3450 [PMID: 15948252 DOI: 10.3748/wjg.v11.i22.3446]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.